LATEST IN PD RESEARCH

Stay informed with the latest breakthroughs in Parkinson’s disease research.
This section highlights newly published studies, emerging treatment approaches, and cutting-edge scientific developments. Whether you’re a researcher, clinician, caregiver, or someone living with PD, here you’ll find accessible updates on the science driving progress.

Updates

New Findings

Rapid Multi-Well Evaluation of Assorted Materials for Hydrogel-Assisted Giant Unilamellar Vesicle Production: Empowering Bottom-Up Synthetic Biology

Rapid Multi-Well Evaluation of Assorted Materials for Hydrogel-Assisted Giant Unilamellar Vesicle Production: Empowering Bottom-Up Synthetic Biology

Reconstitution of BNIP3/NIX-mitophagy initiation reveals hierarchical flexibility of the autophagy machinery

Reconstitution of BNIP3/NIX-mitophagy initiation reveals hierarchical flexibility of the autophagy machinery

Viral overexpression of human alpha-synuclein in mouse substantia nigra dopamine neurons results in hyperdopaminergia but no neurodegeneration

Viral overexpression of human alpha-synuclein in mouse substantia nigra dopamine neurons results in hyperdopaminergia but no neurodegeneration

GBA mutations, glucosylceramide and Parkinson’s disease

GBA mutations, glucosylceramide and Parkinson’s disease

,

A novel alpha-synuclein G14R missense variant is associated with atypical neuropathological features

A novel alpha-synuclein G14R missense variant is associated with atypical neuropathological features

A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease

A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease

Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study

Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study

,

Biomarker-Based Approach to α-Synucleinopathies: Lessons from Neuropathology

Biomarker-Based Approach to α-Synucleinopathies: Lessons from Neuropathology

Widespread distribution of α-synuclein oligomers in LRRK2-related Parkinson’s disease

Widespread distribution of α-synuclein oligomers in LRRK2-related Parkinson’s disease

In vitro modeling of the human dopaminergic system using spatially arranged ventral midbrain–striatum–cortex assembloids

In vitro modeling of the human dopaminergic system using spatially arranged ventral midbrain–striatum–cortex assembloids

The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability

The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability